1. Sex differences in evidence-based processes of care and one-year survival after aneurysmal subarachnoid hemorrhage (ASAH)-reddish study.
- Author
-
Thrift A., Callisaya M., Zhou K., Gall S., Tan D., Rehman S., Chandra R., Lai L., Stirling C., Asadi H., Froelich J., Thani N., Nichols L., Blizzard L., Smith K., Breslin M., Reeves M., Thrift A., Callisaya M., Zhou K., Gall S., Tan D., Rehman S., Chandra R., Lai L., Stirling C., Asadi H., Froelich J., Thani N., Nichols L., Blizzard L., Smith K., Breslin M., and Reeves M.
- Abstract
Background and Aims: Limited evidence exists on clinical management and longer-term survival after aneurysmal subarachnoid hemorrhage (aSAH) including sex differences. We aimed to determine sex differences in the association of optimal evidence-based care with survival. Method(s): We established a retrospective cohort (2010-2016) of all consecutive aSAH cases admitted to two comprehensive cerebrovascular centers in Australia. Survival at one year was obtained by linking cases with the National Death Index. We documented 4 indicators of evidence-based aSAH processes of care: (1) imaging (CTwith CTA/DSA), (2) nimodipine, (3) aneurysm treatment (coiling/clipping) and, (4) antihypertensives in subset with systolic blood pressure (SBP) >=150mmHg and, we calculated 'optimal care' (e.g. received all eligible processes of care).We estimated (1) sex differences in processes of care using t-test/chi-square (2) association between processes of care and sex with 1-year mortality using cox-proportional hazard model adjusting for age, severity, co-morbidities and hospital network. Result(s): Among 575 participants (69% women), only 40% of patients received optimal care. There were no sex differences in processes of care. One-year mortality was 28% with no sex difference. Treatment of the aneurysm, receiving nimodipine and antihypertensive and, receiving 'optimal care' was associated with a lesser hazard of death at 12 months with no differences by sex when adjusted for age, comorbidities and hospital network (fig-1). Conclusion(s): Many people with aSAH do not receive evidence-based care, and this lack of optimal care may impact on their survival.
- Published
- 2021